Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Two new appointments at Eisai

This article was originally published in Scrip

Executive Summary

Eisai (US) has named Steven Sembler senior vice-president of oncology and institutional care and Dr Ann Miller senior vice-president of the primary care and speciality business unit. Mr Sembler joins from Roche, where he most recently served as vice-president of speciality care, commercial operations, where he oversaw Roche's oncology, virology, HIV and anti-infectives business units. Dr Miller was previously in commercialisation and marketing consulting. She has more than 20 years' experience in the biopharmaceutical industry, having formerly worked Merck & Co and Amgen.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC003189

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel